Sign in

CIK 0001817713 · Large accelerated filer

Janux Therapeutics, Inc.

Sign in to watch
Ticker
JANX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
822289112
Phone
(858) 751-4493
Business address
10955 VISTA SORRENTO PARKWAY, SUITE 200, SAN DIEGO, CA, 92130
  1. 4 Insider Changes in Ownership
  2. 8-K Event Shareholder vote results
  3. 4 Insider Changes in Ownership
  4. 3 Insider Initial Statement of Ownership
  5. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  6. 10-Q Report Quarterly Report
  7. 8-K Event Results of operations
  8. 4 Insider Changes in Ownership
  9. 144 Insider Sale of Securities
  10. ARS Other Annual Report to Security Holders
  11. DEFA14A Proxy Proxy Materials
  12. DEF 14A Proxy Proxy Statement
  13. 4 Insider Changes in Ownership
  14. 144 Insider Sale of Securities
  15. SCHEDULE 13D/A Stake Beneficial Ownership Report
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 144 Insider Sale of Securities
  19. S-8 Other Securities Offered to Employees in Benefit Plans
  20. 10-K Report Annual Report

Page 5 of 23 · 442 filings